BBOT
BridgeBio Oncology Therapeutics, Inc.Company with tickers: BBOT
CIK
1869105
CUSIP
107924102
Shares Outstanding
80,107,104
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-10 | Elmelech Idan | COO & Principal Financial Ofcr | Award | 758,222 |
| 2026-05-10 | Beltran Pedro | Chief Scientific Officer | Award | 1,103,837 |
| 2026-04-21 | Cobo Marc | Principal Accounting Officer | Other | 0 |
| 2026-04-21 | Cobo Marc | Principal Accounting Officer | Other | 5,431 |
| 2026-04-21 | Cobo Marc | Principal Accounting Officer | Other | 0 |
| 2026-04-20 | Elmelech Idan | COO & Principal Financial Ofcr | Other | 0 |
| 2026-04-20 | Elmelech Idan | COO & Principal Financial Ofcr | Other | 14,838 |
| 2026-04-20 | Elmelech Idan | COO & Principal Financial Ofcr | Other | 0 |
| 2026-04-20 | Elmelech Idan | COO & Principal Financial Ofcr | Other | 0 |
| 2026-04-20 | Elmelech Idan | COO & Principal Financial Ofcr | Other | 0 |
| 2026-04-01 | Beltran Pedro | Chief Scientific Officer | Tax | 1,047 |
| 2026-04-01 | Mehra Uneek | See Remarks | Tax | 524 |
| 2026-04-01 | Ben Yong | Chief Med & Dev Officer | Tax | 1,047 |
| 2026-03-24 | Lebowitz Peter F | Director | Other | 0 |
| 2026-03-24 | Lebowitz Peter F | Director | Award | 63,350 |
| 2026-03-10 | Ben Yong | Chief Med & Dev Officer | Award | 210,000 |
| 2026-03-10 | Ben Yong | Chief Med & Dev Officer | Award | 46,670 |
| 2026-03-10 | Mehra Uneek | See Remarks | Award | 23,330 |
| 2026-03-10 | Mehra Uneek | See Remarks | Award | 105,000 |
| 2026-03-10 | Beltran Pedro | Chief Scientific Officer | Award | 46,670 |
| 2026-03-10 | Beltran Pedro | Chief Scientific Officer | Award | 210,000 |
| 2026-01-01 | Wallace Eli M. | Director, Chief Executive Officer | Award | 1,114,400 |
| 2025-12-10 | Wallace Eli M. | Director, Chief Executive Officer | Other | 1,114,400 |
| 2025-10-02 | Wallace Eli M. | Director, Chief Executive Officer | Award | 1,614,400 |
| 2025-08-26 | Bauer Jake | Director | Award | 138,193 |
| 2025-08-26 | Beltran Pedro | Chief Scientific Officer | Award | 357,177 |
| 2025-08-26 | Tipirneni Praveen P. | Director | Award | 52,269 |
| 2025-08-26 | MCCORMICK FRANK | Director | Award | 91,076 |
| 2025-08-26 | Ben Yong | Chief Med & Dev Officer | Award | 357,177 |
| 2025-08-26 | Wallace Eli M. | Director, Chief Executive Officer | Award | 499,731 |
| 2025-08-26 | Mehra Uneek | See Remarks | Award | 633,570 |
| 2025-08-11 | Beltran Pedro | Chief Scientific Officer | Other | 0 |
| 2025-08-11 | Beltran Pedro | Chief Scientific Officer | Other | 0 |
| 2025-08-11 | Kumar Neil | Director | Other | 0 |
| 2025-08-11 | MCCORMICK FRANK | Director | Other | 0 |
| 2025-08-11 | MCCORMICK FRANK | Director | Other | 0 |
| 2025-08-11 | DOIG MICHELLE | Director | Other | 0 |
| 2025-08-11 | Tipirneni Praveen P. | Director | Other | 0 |
| 2025-08-11 | Tipirneni Praveen P. | Director | Other | 0 |
| 2025-08-11 | Schmid John P. | Director | Convert | 30,000 |
| 2025-08-11 | Schmid John P. | Director | Convert | 30,000 |
| 2025-08-11 | McKenna Mark C. | Director | Convert | 30,000 |
| 2025-08-11 | Kelleher Raymond J. | Director | Other | 0 |
| 2025-08-11 | Ben Yong | Chief Med & Dev Officer | Other | 0 |
| 2025-08-11 | Ben Yong | Chief Med & Dev Officer | Other | 0 |
| 2025-08-11 | Bauer Jake | Director | Other | 0 |
| 2025-08-11 | McKenna Mark C. | Director | Convert | 30,000 |
| 2025-08-11 | Holman Albert A III | Insider | Convert | 30,000 |
| 2025-08-11 | Holman Albert A III | Insider | Convert | 30,000 |
| 2025-08-11 | Wallace Eli M. | Director, Chief Executive Officer | Other | 0 |
| 2025-08-11 | Wallace Eli M. | Director, Chief Executive Officer | Other | 0 |
| 2025-08-11 | Mehra Uneek | See Remarks | Other | 0 |
| 2025-08-11 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Award | 639,110 |
| 2025-08-11 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Award | 284,571 |
| 2025-08-11 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Award | 1,762,760 |
| 2025-08-11 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Convert | 4,172,126 |
| 2025-08-11 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Award | 1,905,046 |
| 2025-08-11 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Award | 760,496 |
| 2025-08-11 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Other | 152,940 |
| 2025-08-11 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Other | 307,874 |
| 2025-08-11 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Award | 5,598,425 |
| 2025-08-11 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Convert | 4,172,126 |
| 2025-08-11 | Obradovic Nebojsa | Chief Legal Officer | Other | 0 |
| 2025-08-11 | Tripp Caleb | CFO & COO | Other | 0 |
| 2025-02-08 | Holman Albert A III | Insider | Other | 0 |
| 2025-02-08 | Helix Holdings II LLC | Director, 10% Owner | Other | 30,000 |
| 2025-02-08 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Other | 30,000 |
| 2024-02-13 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Buy | 903,600 |
| 2024-02-13 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Buy | 69,360 |
| 2024-02-13 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Buy | 1,427,040 |
| 2024-02-13 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Award | 509,000 |
| 2024-02-13 | Helix Holdings II LLC | Director, 10% Owner | Award | 509,000 |
| 2024-02-08 | Chen Bihua | Director, Chairperson and CEO, 10% Owner | Other | 0 |
| 2024-02-08 | Tripp Caleb | CFO & COO | Other | 0 |
| 2024-02-08 | Helix Holdings II LLC | Director, 10% Owner | Other | 0 |
| 2024-02-08 | Obradovic Nebojsa | Chief Legal Officer | Other | 0 |
| 2024-02-08 | McKenna Mark C. | Director | Other | 0 |
| 2024-02-08 | Schmid John P. | Director | Other | 0 |